Media-OutReach Newswire Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins
Media-OutReach Newswire China Tower Continues to Deepen "One Core and Two Wings" Development Strategy
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.